PhalconBio GmbH

PhalconBio develops antimicrobial precision medicine, making a significant contribution to combating the global antibiotic resistance crisis. PhalconBio’s innovative approach leverages bacteriophages—the natural predators of bacteria—that specifically identify and eliminate pathogens. Using its platform technology, PhalconBio significantly enhances the efficacy, safety, and sustainability of phage therapeutics.

The result: an effective and safe alternative to antibiotics, setting a new standard in antibacterial treatment.